Related Experiment Videos
The NADPH-dependent O-.2-generating oxidase from human neutrophils
The Journal of Biological Chemistry
|May 25, 1983
Summary
Researchers investigated the neutrophil NADPH oxidase system in chronic granulomatous disease (CGD). Two CGD patients showed distinct defects in flavoprotein and cytochrome b, suggesting separate genetic mutations affecting this crucial oxygen-generating pathway.
Area of Science:
- Cellular Biology
- Immunology
- Biochemistry
Background:
- Neutrophils utilize NADPH oxidase to generate superoxide (O2-), a key component of the respiratory burst.
- Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by defects in this NADPH oxidase system.
- Previous work identified a subcellular particulate fraction enriched in NADPH-dependent O2- generating activity.
Purpose of the Study:
- To further characterize the components of the neutrophil NADPH oxidase system.
- To investigate the roles of flavin adenine dinucleotide (FAD)-containing flavoprotein and cytochrome b in NADPH oxidase activity.
- To identify potential distinct genetic defects in CGD patients affecting these components.
Main Methods:
- Characterization of a subcellular particulate fraction from normal neutrophils, quantifying flavin adenine dinucleotide and cytochrome b content.
- Selective bile salt extraction to resolve flavoprotein from cytochrome b.
- Analysis of similar neutrophil fractions from two CGD patients, assessing cytochrome b spectral properties and FAD content, and flavoprotein via fluorescence spectroscopy.
Main Results:
- Normal neutrophil fractions contained significant flavin adenine dinucleotide and cytochrome b.
- One CGD patient's fraction showed abnormal cytochrome b but normal FAD and flavoprotein spectra.
- The second CGD patient's fraction had normal cytochrome b but severely reduced FAD and undetectable flavoprotein.
Conclusions:
- The findings suggest that flavoprotein and cytochrome b are distinct components of the neutrophil NADPH oxidase system.
- The two CGD patients likely represent distinct genetic mutations affecting these separate components.
- This provides evidence for separate genetic loci controlling flavoprotein and cytochrome b in the NADPH oxidase complex.